Byline: Melissa Rohman
-
Medical Student Discusses Neurosurgery Research
Nathan Shlobin, a second-year medical student, was the first author of a study recently published in the Journal of Neurosurgery, which identified through systematic review potential risk factors for spinal cord ischemia related to anterior thoracolumbar surgery.
-
Novel Drug May Improve Treatment for Duchenne Muscular Dystrophy
A novel drug may improve the efficacy of corticosteroid treatment for patients with Duchenne muscular dystrophy and overall quality of life, according to a recent clinical trial.
-
Northwestern Medicine Scientists Lead Project to Develop Novel Female Contraceptives
A multi-institution team of investigators led by Northwestern Medicine scientists has received an $8 million grant for the identification of novel biological targets to develop non-hormonal contraceptives for women in developing countries.
-
Promoting Gender Equity in Academic Medicine During COVID-19
A recent Northwestern Medicine perspective piece published in journal Academic Medicine discussed how the COVID-19 pandemic could impact gender equity within the field, specifically the retention and advancement of women.
-
Northwestern Medicine Scientists Receive Multimillion-dollar Grant to Continue Landmark Parkinson’s Study
Tanya Simuni, MD, director of the Parkinson’s Disease and Movement Disorders Center, has received a multimillion-dollar grant from The Michael J. Fox Foundation to identify biomarkers of Parkinson’s disease progression for use in clinical trials for novel therapies.
-
Healy Receives Physician Assistant Lifetime Achievement Award
Kristine Healy, MPH, PA-C, assistant professor of Medical Education and associate director of Feinberg’s Physician Assistant program, has received the Illinois Academy of Physician Assistants’ Lifetime Achievement Award for her service and dedication to physician assistant advocacy, education and clinical practice.
-
Targeting Proteins May Help Eliminate Radioresistant Breast Cancer Cells
Targeting the proteins CD47 and HER2 may eliminate radioresistant breast cancer cells and enable more effective radiotherapy treatments for patients, according to a new study.
-
Soulakis Discusses COVID-19 Contract Tracing Efforts with IDPH
Nicholas Soulakis, PhD, assistant professor of Preventive Medicine in the Divisions of Health and Biomedical Informatics and Epidemiology, discussed lessons learned from his experience leading COVID-19 contract tracing efforts for the Illinois Department of Public Health during a recent webinar.
-
How COVID-19 Impacts Cancer Care and Research
The impact of COVID-19 on cancer patients has been a stark reality for many cancer centers around the world. For the Robert H. Lurie Comprehensive Cancer Center of Northwestern University, a combination of time and dedication to patient care and research has resulted in the development of robust COVID-19 testing protocols to ensure the safety…
-
Study Provides Insights into the Development of Alzheimer’s
A rare genetic mutation found in patients with Alzheimer’s may provide further insight into the pathologic mechanisms that cause the disease.
